...
机译:“EGFR中常见和罕见突变的表征和相关临床病理特征在大量肺癌患者中表征”的勘探[病理学 - 研究与实践213(2017)749-758]
The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital No 127 Dongming Road;
The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital No 127 Dongming Road;
The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital No 127 Dongming Road;
The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital No 127 Dongming Road;
The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital No 127 Dongming Road;
The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital No 127 Dongming Road;
The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital No 127 Dongming Road;
Sanford Burnham Prebys Medical Discovery Institute;
The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital No 127 Dongming Road;
The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital No 127 Dongming Road;
机译:“EGFR中常见和罕见突变的表征和相关临床病理特征在大量肺癌患者中表征”的勘探[病理学 - 研究与实践213(2017)749-758]
机译:“临床实验室检测热点癌突变检测下一代测序面板的勘探”[日志信息:2017年,第213卷,第2卷,第2页:98-105]
机译:中国大陆非小细胞肺癌患者EGFR基因突变及其与临床病理特征的关系:荟萃分析
机译:接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
机译:中国大陆非小细胞肺癌患者EGFR突变及其与临床病理特征的关系:荟萃分析
机译:荷兰非小细胞肺癌人群中常见和罕见的EGFR和KRAS突变及其临床结果